Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
SamaGong's Profile
Displaying 101-150 of 312 result(s).
CYDY CytoDyn Inc
12/29/2023 2:43:45 PM
The Chicago Way (or maybe it's the (14)
CYDY CytoDyn Inc
12/19/2023 3:50:49 PM
I'll be fine with being wrong, but (2)
CYDY CytoDyn Inc
12/17/2023 12:52:31 PM
Always trying to learn more, while
CYDY CytoDyn Inc
12/16/2023 10:26:25 AM
1. Stage 4 breast cancer - Widely m (5)
CYDY CytoDyn Inc
12/15/2023 7:14:06 PM
SeeWhyDY, For me, this was the unde (3)
CYDY CytoDyn Inc
12/15/2023 11:02:40 AM
I haven't searched and don't have a (1)
CYDY CytoDyn Inc
12/14/2023 9:39:14 AM
Last night's topic of using LL as a (10)
CYDY CytoDyn Inc
12/13/2023 2:36:46 PM
Gosh I hope '23 is the last year we (5)
CYDY CytoDyn Inc
12/13/2023 1:36:41 PM
You can buy or sell anytime you wan (3)
CYDY CytoDyn Inc
12/13/2023 1:24:51 PM
Got it, so the 30 day clock started
CYDY CytoDyn Inc
12/13/2023 12:50:55 PM
I'm not aware of a 61-day guideline (1)
CYDY CytoDyn Inc
12/07/2023 3:05:57 PM
Drat. Was it Bucweey's post or my l
CYDY CytoDyn Inc
12/05/2023 5:39:34 PM
Drano, not attacking, not offering (6)
CYDY CytoDyn Inc
11/07/2023 11:57:57 AM
Plotinus, thanks for this snippet f (6)
CYDY CytoDyn Inc
10/10/2023 9:31:08 AM
Drano, Here I am, typing when I don (2)
CYDY CytoDyn Inc
10/03/2023 6:39:59 PM
Cassandra, Thanks for your reply. I (3)
CYDY CytoDyn Inc
10/03/2023 3:09:21 PM
Cassandra, thanks for your efforts. (1)
CYDY CytoDyn Inc
09/15/2023 10:33:33 AM
Vax? Paxlovid? Yikes. Are you long (5)
CYDY CytoDyn Inc
09/14/2023 8:37:58 AM
10k's Current Business Strategies1- (1)
CYDY CytoDyn Inc
09/05/2023 10:43:53 AM
I interpreted the "Pfizer Ivermecti (1)
CYDY CytoDyn Inc
07/27/2023 8:45:46 PM
When you typed "in-vitro animal stu
CYDY CytoDyn Inc
07/27/2023 8:37:28 PM
You're right (of course). I think o (3)
CYDY CytoDyn Inc
07/27/2023 4:23:29 PM
The current uber-popular and heavil (6)
CYDY CytoDyn Inc
07/27/2023 2:34:51 PM
You know, trying to keep it positiv (5)
CYDY CytoDyn Inc
07/27/2023 7:57:55 AM
Drano, As we enter another period o (1)
CYDY CytoDyn Inc
07/24/2023 8:49:32 AM
Open letter: (2)
CYDY CytoDyn Inc
06/23/2023 9:07:37 AM
Many thanks to Ohm for the ongoing (9)
CYDY CytoDyn Inc
04/14/2023 10:06:25 AM
For me, that was one takeaway from (3)
CYDY CytoDyn Inc
04/12/2023 10:32:17 AM
I like being part of this village. (9)
CYDY CytoDyn Inc
04/11/2023 9:18:21 AM
When I read Enjay's page 39 post of (4)
CYDY CytoDyn Inc
04/06/2023 5:52:14 PM
NIH grant to Sacha/OHSU is for stud
CYDY CytoDyn Inc
03/02/2023 9:21:17 AM
Possible addition to the disease li (3)
CYDY CytoDyn Inc
02/15/2023 9:17:57 AM
Cyrus has mentioned attacking color (3)
CYDY CytoDyn Inc
02/15/2023 8:57:54 AM
In other news, the 13d group that w (12)
CYDY CytoDyn Inc
01/21/2023 8:43:50 AM
Morning, Biloxi! I read your one-li (2)
CYDY CytoDyn Inc
01/14/2023 9:00:08 AM
From the While We Wait post: 1. Bla (2)
CYDY CytoDyn Inc
01/02/2023 10:33:54 AM
CXCR4 antagonist: the publicly trad (1)
CYDY CytoDyn Inc
12/29/2022 9:11:28 AM
Good story, Chazzle! Some of those (1)
CYDY CytoDyn Inc
12/22/2022 11:12:32 AM
Hulk, You're typing that you're buy (4)
CYDY CytoDyn Inc
12/22/2022 9:05:50 AM
Hi docj, From your post: "company h (2)
CYDY CytoDyn Inc
12/20/2022 2:20:01 PM
Hey Craig, Thanks for your support.
CYDY CytoDyn Inc
12/20/2022 1:51:02 PM
Oh man, gut punch for sure. Feeling (1)
CYDY CytoDyn Inc
12/09/2022 9:00:34 AM
No fair. I'm gonna tell. Respert (o (5)
CYDY CytoDyn Inc
12/07/2022 2:06:18 PM
OK, so after the call, we're back t (3)
CYDY CytoDyn Inc
12/07/2022 1:56:41 PM
In your career, did you/other colle (2)
CYDY CytoDyn Inc
12/07/2022 9:02:16 AM
Part of my 10/08/2022 post: 3. CR m (3)
CYDY CytoDyn Inc
12/03/2022 1:30:18 PM
Enjay, I Enjoy your posts and finds (7)
CYDY CytoDyn Inc
12/01/2022 8:40:03 AM
The Amyloid Treatment Guy showed up (4)
CYDY CytoDyn Inc
11/22/2022 9:08:53 AM
Let the next avoidable Macbeth tea (4)
CYDY CytoDyn Inc
10/29/2022 10:44:53 AM
I'll type in a vague way to express (2)
Go to page:
  • << First
  • < Previous
  • 2
  • 3
  • Next >

Recent Articles

  • Groundbreaking Study at Kanazawa University Uncovers Cancer Cell Flexibility
  • Agilyx Secures EUR 20 Million in Convertible Bond Placement
  • Harnessing AI for Global Anti-Corruption: A New Horizon
  • Agilyx Secures EUR 20 Million for Its Convertible Bond Initiative
  • US Stocks Rally as Trade Talks Progress Amid Investor Optimism
  • Evolving Expectations: PayPal Prepares for Third Quarter Results
  • HTX Select Q3 Report: Insights on 38 Listings and Market Trends
  • Bavarian Nordic Enhances Vaccine Support for Mpox in Africa
  • Outstanding Performance in the Latest Quarter Revenue Report
  • Denmark's Public Takeover Offer: Key Details for Shareholders
  • Truecaller Reports Significant Growth Amid External Challenges
  • Intellistake Enhances Validator Portfolio with Major FET Tokens
  • Socionext Launches Flexible Chiplet Ecosystem for Innovation
  • Raytron's Innovative Thermal Cameras Enhance Off-Road Safety
  • TSUN Revolutionizes Solar Adoption in EU with New Certifications
  • Analysts Adjust Expectations for UnitedHealth's Q3 Earnings
  • Introducing the Innovative MS1180 High-Performance XO Module
  • MemorialCare Hospitals Recognized for Exceptional Patient Care
  • BioCina Welcomes Dr. Broudy as New CEO for Growth Strategy
  • Aluminum Wire Rod Market Growth Forecast for Future Success
  • Join the Leading Innovators at the 27th China Clean Expo
  • Unilumin's Strategic Move: From Display Hardware to AI Services
  • Eesti Energia Announces New Management Board for 2026
  • Transforming Africa's AI Landscape: The Impact of GAIME 2025
  • Recent Developments in ING's Share Buyback Strategy
  • Tesla Roadster Job Listings Hint at Upcoming Production Phase
  • Truecaller Shows Resilience Amid Challenges in Revenue Growth
  • Market Trends: Stocks to Monitor This Week Including Visa
  • Swarm Oncology Expands T Cell Therapy Research With New Clinic
  • REFI Sun UAB Achieves Milestone in Green Bond Offering Success
  • OP Corporate Bank Achieves Significant Growth in 2025 Interim Report
  • NB Private Equity Partners' Recent Share Buyback Initiative
  • SATO Corporation: Thriving Through Strategic Investments in Housing
  • Exciting New Gold Discoveries Unveiled by Amaroq Ltd.
  • OSB Group PLC Enhances Shareholder Value with Buyback Scheme
  • Foresight Group's Share Buyback Program Enhances Value
  • ING's Share Buyback Program: Success and Future Plans
  • ICG Enterprise Trust plc's Recent Share Buyback Announcement
  • Equinor ASA Wraps Up Third Phase of 2025 Share Buy-Back
  • Elis Shares Buybacks: A Strategic Move for Future Holdings
  • Christian Petrov Takes Charge of Arco Vara's Bulgarian Team
  • Exciting Dividend Announcement from AKVA Group ASA Today
  • DMG Blockchain and Malahat Nation Forge Groundbreaking Clean Energy Partnership
  • Samsung Biologics Achieves Noteworthy Q3 Milestones
  • Navamedic ASA Announces Growth and Strategic Acquisitions Ahead
  • Investors Alarmed by Molina Healthcare, Inc. Securities Fraud Claims
  • Unilumin's Innovative Leap: AI Services for Diverse Industries
  • Shanghai's AI Ecosystem Thrives: Innovations and Opportunities Ahead
  • Samsung Biologics Achieves Record Growth in Q3 2025 Results
  • Sampo plc's Significant Share Buybacks on October 27, 2025
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site